Phibro Animal Health (PAHC) Other Non-Current Assets (2013 - 2026)

Phibro Animal Health's (PAHC) quarterly Other Non-Current Assets came in at $18.8 million in Q1 2026, up 376.74% year-on-year from $3.9 million in Q1 2025, and down 2.59% quarter-over-quarter from $19.3 million in Q4 2025.

Phibro Animal Health (PAHC) Other Non-Current Assets (2013 - 2026) Analysis & Trends

Phibro Animal Health's Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $18.8 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 376.74% year-over-year to $18.8 million in Q1 2026; TTM through Mar 2026 was $18.8 million, a 376.74% increase from a year earlier, with the FY2025 full-year figure at $99.5 million, up 1267.18% from the prior year.
  • Other Non-Current Assets declined to $18.8 million in Q1 2026 per PAHC's latest filing, from $19.3 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $99.5 million in Q2 2025 and bottomed at $623000.0 in Q3 2024.
  • The 5-year median for Other Non-Current Assets is $8.0 million (2023), against an average of $18.2 million.
  • Across the five-year window, Other Non-Current Assets plunged 98.03% in 2022 and surged 2963.56% in 2025, its largest moves.
  • Year by year, Other Non-Current Assets stood at $7.6 million in 2022, then surged by 951.19% to $79.6 million in 2023, then tumbled by 80.2% to $15.8 million in 2024, then advanced by 22.52% to $19.3 million in 2025, then fell by 2.59% to $18.8 million in 2026.
  • Per Business Quant, the three latest PAHC Other Non-Current Assets figures stand at $18.8 million (Q1 2026), $19.3 million (Q4 2025), and $19.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Phibro Animal Health 1.38 Bn 1.30 Bn 125.68 Mn 18.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.82 Mn
Dec 31, 2025 19.32 Mn
Sep 30, 2025 19.09 Mn
Jun 30, 2025 99.49 Mn
Mar 31, 2025 3.95 Mn
Dec 31, 2024 15.77 Mn
Sep 30, 2024 623,000.00
Jun 30, 2024 7.28 Mn
Mar 31, 2024 2.34 Mn
Dec 31, 2023 79.64 Mn
Sep 30, 2023 7.79 Mn
Jun 30, 2023 8.03 Mn
Mar 31, 2023 1.53 Mn
Dec 31, 2022 7.58 Mn
Sep 30, 2022 8.52 Mn
Jun 30, 2022 1.44 Mn
Mar 31, 2022 8.77 Mn
Dec 31, 2021 5.24 Mn
Sep 30, 2021 8.53 Mn
Jun 30, 2021 72.75 Mn